Jad Othman

Jad Othman is a male medical professional who helps patients with different health issues like Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant. He also treats conditions like Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Graft Versus Host Disease (GvHD), Hemolysis, and Hemolytic Transfusion Reaction.

Jad Othman uses special skills and treatments to take care of patients and make them feel better. He talks to patients in a way that makes them feel comfortable and safe, which is why patients trust him.

Jad Othman keeps learning about new medical information and research to make sure he is always up-to-date. This helps him provide the best care for his patients.

Jad Othman works well with other medical professionals and has good relationships with his colleagues. They all work together to help patients get the best treatment possible.

Jad Othman's work has had a positive impact on many patients' lives. For example, his research on AML and venetoclax-based therapy has helped improve survival rates for patients with this condition.

One of Jad Othman's notable publications is "Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML," which was published in Blood on September 13, 2024.

Overall, Jad Othman is a caring and knowledgeable medical professional who works hard to help his patients and improve their health. He is dedicated to staying informed about the latest medical advancements and collaborates effectively with his colleagues to provide the best possible care.